Lupin, Concord Biotech get USFDA nod for generic immunosuppressant capsules
Posted by
www.biotecnika.org
In alliance with Concord Biotech, the company has received approval
from the United States Food and Drug Administration (USFDA) to market
Tacrolimus capsules USP, in the strengths of 0.5 mg, 1 mg, and 5 mg,
Lupin said in a filing to the BSE.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-usfda-nod-for-generic-immunosuppressant-capsules/articleshow/79191354.cms
Subscribe to:
Post Comments (Atom)
Post a Comment